The patent relates to a transcutaneous modulated power link for a medical implant, in particular for a hearing aid acting on the middle ear.
Brief outline of the case
The opposition was rejected and the opponent appealed.
The OD considered that the independent method claim was not to be considered as a therapeutic method and that the device claims were novel and inventive over the prior art cited by the opponent.